Creative Planning Isoray, Inc. Transaction History

Creative Planning

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	N/A	45,000 Added 32.49%	183,500 $126,000
Q4 2023 Feb 14, 2024	BUY	N/A	9,000 Added 6.95%	138,500 $95,000
Q3 2023 Nov 16, 2023	SELL	N/A	-5,000 Reduced 3.72%	129,500 $89,000
Q2 2023 Jul 21, 2023	BUY	$0.0 - $0.69 $0 - $3,449	5,000 Added 3.86%	134,500 $92,000
Q1 2022 May 16, 2022	BUY	$0.31 - $0.41 $4,650 - $6,150	15,000 Added 13.1%	129,500 $47,000
Q2 2021 Aug 04, 2021	SELL	$0.75 - $1.15 $75 - $114	-100 Reduced 0.09%	114,500 $91,000
Q1 2021 Apr 30, 2021	BUY	$0.53 - $2.47 $7,321 - $34,123	13,815 Added 13.71%	114,600 $125,000
Q3 2020 Nov 05, 2020	BUY	$0.54 - $0.78 $42,543 - $61,452	78,785 Added 358.11%	100,785 $59,000
Q1 2020 May 05, 2020	BUY	$0.53 - $0.99 $11,660 - $21,780	22,000 New	22,000 $12,000

287K

Ticker ISR
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 142,112,992
Market Cap $98.1M
Description
Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and nec...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.